Cubicle CACS 412 (severe coronary calcium) + LDL 168 — 9.5× Bayesian lift on 10-yr ASCVD risk.
Marcus is firmly in the high-risk band. CACS >300 alone places 10-yr ASCVD risk >20%, regardless of pooled-cohort equation output. AHA/ACC 2018 Cholesterol Guideline mandates high-intensity statin + lipid clinic referral.
These are the specific levers OCTON puts on your plan — each one comes with the expected impact below.
Agatston coronary artery calcium score 412 (LAD 218, LCx 86, RCA 108). Severe coronary calcification consistent with established atherosclerosis. No critical luminal stenosis identified on contrast pass.
Marcus walked into the cubicle for a routine annual scan. He felt fine. Twenty minutes later, a coronary calcium score of 412 lit up an Agatston band that 96% of 52-year-olds never see. The Bayesian engine moved his 10-year ASCVD probability from 4.1% (pooled-cohort default) to 39.2% — a 9.5× lift. Untreated, his lipid panel + smoking + Stage-2 BP + impaired glucose stacked multiplicatively into a trajectory that would shorten his projected life by ~20 years — first MACE in his mid-50s. Same-day high-intensity statin + ASA + ACEi + smoking cessation programme + Mediterranean diet + 150 min/wk Z2. Two years later: LDL 64, BP 124/76, asymptomatic, tobacco-free. Marcus's likely first-MI age moved from his late 50s to his late 70s — a 28-year recovery of projected life and ~9 years above the average US 52-yo who never had his risk factors.
Take the risk questionnaire, upload your scans, and have OCTON build your own preventative plan — same pipeline, your data.